HC Surgical Specialists Ltd (SG:1B1)
SGX:1B1
Want to see SG:1B1 full AI Analyst Report?
1B1 Stock Chart & Stats
S$0.36
S$0.00(0.00%)
At close: 4:00 PM EST
S$0.36
S$0.00(0.00%)
Day’s Range― - ―
52-Week RangeS$0.26 - S$0.39
Previous CloseN/A
Volume0.00
Average Volume (3M)50.29K
Market Cap
S$56.91M
Enterprise ValueS$54.44M
Total Cash (Recent Filing)S$5.73M
Total Debt (Recent Filing)S$2.78M
Price to Earnings (P/E)5.2
Beta0.06
Next Earnings
Jul 23, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.37%
Share Statistics
EPS (TTM)0.03
Shares Outstanding156,309,900
10 Day Avg. Volume16,820
30 Day Avg. Volume50,290
Financial Highlights & Ratios
PEG Ratio0.04
Price to Book (P/B)2.09
Price to Sales (P/S)2.29
P/FCF Ratio6.49
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
High ProfitabilityElevated gross and operating margins indicate strong pricing power and a tightly controlled cost base across procedures. Such margin levels support durable cash generation, enable funding of dividends and reinvestment, and provide a structural buffer against volume volatility that preserves long-term profitability.
De-risked Balance SheetSubstantially lower leverage materially reduces refinancing and solvency risk, improving financial flexibility. A stronger capital structure supports steady distributions, allows selective capital spending or acquisitions, and increases resilience to sector shocks over a multi-month to multi-year horizon.
Strong Cash ConversionConsistent positive operating cash flow and near-par FCF-to-net-income conversion demonstrate reliable internal funding. This reduces reliance on external financing, supports sustainable dividends and necessary maintenance capex, and underpins the company’s ability to weather temporary revenue weakness.
Bears Say
Declining RevenuePersistent and sharply negative top-line growth undermines utilization of clinic capacity and pressures fixed-cost absorption. Even with high margins, continued revenue decline threatens margin sustainability, limits operational leverage, and constrains long-term earnings and reinvestment potential.
Weak Free Cash Flow MomentumDespite positive absolute FCF, deteriorating FCF growth curtails the firm’s ability to expand services or increase strategic investments. Falling FCF momentum reduces the margin of safety for dividends and capital projects, signaling weakening operational throughput or demand trends.
Small Scale & ConcentrationA small workforce and concentrated single-market, niche-service footprint limit scale economies, bargaining power with payors, and geographic diversification. This concentration raises vulnerability to local demand shifts, regulatory changes, and constrains long-term growth and margin expansion opportunities.
HC Surgical Specialists Ltd News
1B1 FAQ
What was HC Surgical Specialists Ltd’s price range in the past 12 months?
HC Surgical Specialists Ltd lowest share price was S$0.26 and its highest was S$0.39 in the past 12 months.
What is HC Surgical Specialists Ltd’s market cap?
HC Surgical Specialists Ltd’s market cap is S$56.91M.
When is HC Surgical Specialists Ltd’s upcoming earnings report date?
HC Surgical Specialists Ltd’s upcoming earnings report date is Jul 23, 2026 which is in 86 days.
How were HC Surgical Specialists Ltd’s earnings last quarter?
HC Surgical Specialists Ltd released its earnings results on Jan 13, 2026. The company reported S$0.026 earnings per share for the quarter, beating the consensus estimate of N/A by S$0.026.
Is HC Surgical Specialists Ltd overvalued?
According to Wall Street analysts HC Surgical Specialists Ltd’s price is currently Overvalued.
Does HC Surgical Specialists Ltd pay dividends?
HC Surgical Specialists Ltd pays a Notavailable dividend of S$0.012 which represents an annual dividend yield of 3.37%. See more information on HC Surgical Specialists Ltd dividends here
What is HC Surgical Specialists Ltd’s EPS estimate?
HC Surgical Specialists Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does HC Surgical Specialists Ltd have?
HC Surgical Specialists Ltd has 156,309,900 shares outstanding.
What happened to HC Surgical Specialists Ltd’s price movement after its last earnings report?
HC Surgical Specialists Ltd reported an EPS of S$0.026 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -2.571%.
Which hedge fund is a major shareholder of HC Surgical Specialists Ltd?
Currently, no hedge funds are holding shares in SG:1B1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
HC Surgical Specialists Ltd
HC Surgical Specialists Limited, an investment holding company, provides medical services primarily in Singapore. The company provides endoscopic procedures, including gastroscopies and colonoscopies; and general surgery services with a focus on colorectal procedures in a network of clinics. It also offers treatment services for other conditions, such as haemorrhoids, anal fissure, hernia, anal abscess, cholecystitis, anal fistula, appendicitis, colorectal cancer, lipomas, cysts, and gastric cancer, vein laser vascular, laparoscopy, and other general and specialized medical services. In addition, the company provides orthopedic services comprising joint pain, sports injuries, osteoarthritis, rotator cuff tears, trigger finger, wounds/lumps, tenosynovitis, tunnel syndrome, bumps, joint replacement, arthroscopic surgery, knee osteotomy, realignment surgery, endoscopic spine surgery, disc replacements, spinal decompression, fractures, and orthobiologic injections. Further, it provides home care services, which include medical, nursing, physiotherapy, speech therapy, occupational therapy, and ambulance services; health screening, management of acute and chronic conditions, and pre-employment check-up; public health preparedness clinic scheme, swab and send home program, community health assist scheme, and COVID-19 swab test services. Additionally, the company offers diagnostic tests that comprise blood tests, X-Rays, ultrasound, CT scans, and MRIs. HC Surgical Specialists Limited was incorporated in 2015 and is based in Singapore.
Technical Analysis
Hyphens Pharma International Ltd.
―
Medtecs International Corporation Ltd.
―
UG Healthcare Corp. Ltd.
―
Alliance Healthcare Group Ltd.
―
Medinex Ltd.
―